| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |